5Garg SK,Rosentock J. Optimized basel-lolus insulin regimens in type l diabetes: insulin glulisine versus regular human insulin un combination with basal insulin glargine [ J ]. Endocr Pract, 2005,11 (2) : 145.
10Bott S,Tusek C,Jacobsen LV,et al. Insulin determir understeady - state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with type I diabetes[J]. Diabel Med,2006,23(5): 552.
5Mamone G,Picariello G,Caira S,et al.Analysis of food proteins and peptides by mass spectrometrybased techniques[J].J Chromatogr A,2009,1216(43):7130.
6Thevis M,Thomas A,Schnzer W.Doping control analysis of selected peptide hormones using LCMS(/MS) [J].Forensic Sci Int,2011,213(13):35.
7Sieber P,Eisler K,Kamber B,et al.Synthesis and biological activity of two disulphide bond isomers of human insulin:[A7A11,A6B7cystine] and[A6A7,AllB7cystine] insulin (human) [J].Hoppe Seylers Z Physiol Chem,1978,359(1):113.
8Olsen HB,Ludvigsen S,Kaarsholm NC.Solution structure of an engineered insulin monomer at neutral pH[J].Biochemistry,1996,35(27):8836.
9Wu J,Watson JT.A novel methodology for assignment of disulfide bond pairings in proteins[J].Protein Sci,1997,6(2):391.
10Qi J,Wu J,Somkuti GA,et al.Determination of the disulfide structure of sillucin,a highly knotted,cysteinerich peptide,by cyanylation/cleavage mass mapping[J].Biochemistry, 2001,40(15):4531.
